Dr. Dason on selecting neoadjuvant or adjuvant therapy for patients with UTUC

Video

“We definitely don't have a clear standard,” says Shawn Dason, MD, FRCSC.

In this video, Shawn Dason, MD, FRCSC, discusses the factors that urologists should consider when counseling patients with upper tract urothelial carcinoma about neoadjuvant and adjuvant treatment options. These insights stem from a study that was presented at the 2022 Society of Women in Urology Annual Clinical Mentoring Conference. Dason is a urologic oncologist and an assistant professor of urology at The Ohio State University in Columbus.

Related Videos
Kevin Turner MA DM FRCS(Urol), answers a question during a Zoom video interview
human kidney stones medical concept | Image Credit: © freshidea - stock.adobe.com
Raveen Syan, MD, FPMRS, answers a question during a Zoom video interview
Edward M. Schaeffer, MD, PhD, answers a question during a Zoom video interview
Woman talking with doctor | Image Credit: © bongkarn - stock.adobe.com
Cyber big data flow | Image Credit: © Siarhei - stock.adobe.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.